1. Home
  2. Buyout

Category: Sengenics

Summa Equity picks up majority stake in protein production, research specialist Sengenics

Stockholm's Summa Equity has bought a majority stake in protein production and research specialist Sengenics through its €610m second fund.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.